Epitomee Medical Ltd (EPIT) — Financial Flexibility Index
Epitomee Medical Ltd (EPIT) has a Financial Flexibility Index of -1.78x as of June 2025. Free cash flow of ILA-11.23 Million (operating CF ILA-12.78 Million minus capex ILA1.56 Million) represents -2% of total liabilities (ILA6.32 Million). Also explore Epitomee Medical Ltd (EPIT) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Epitomee Medical Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Epitomee Medical Ltd across 6 annual periods. Check EPIT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Epitomee Medical Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Epitomee Medical Ltd. For the full company profile including market capitalisation, see market value of Epitomee Medical Ltd.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.59x | ILA-3.68 Million | ILA-8.29 Million | ILA6.26 Million | ▲ +16.6% |
| 2023 | -0.70x | ILA-3.85 Million | ILA-7.92 Million | ILA5.46 Million | ▼ -93.9% |
| 2022 | -0.36x | ILA-5.72 Million | ILA-9.42 Million | ILA15.76 Million | ▲ +13.7% |
| 2021 | -0.42x | ILA-5.36 Million | ILA-5.76 Million | ILA12.73 Million | ▼ -206.5% |
| 2020 | 0.40x | ILA6.85 Million | ILA6.75 Million | ILA17.34 Million | ▲ +111.8% |
| 2019 | -3.36x | ILA-2.67 Million | ILA-2.79 Million | ILA794.00K | — |